Fish Oil Can Prevent Heart Attacks, Study Suggests
A Vitamin D and Omega-3 (fish oil) trial shows promise in the prevention of cancer deaths and heart attacks, a new study suggests.
Although results have been mixed, they show promise for some outcomes which has now been confirmed by updated meta analyses, according to the researchers.
Nearly 26,000 US men and women participated in the nationwide VITAL clinical trial.
After more than five years of study and treatment, the results show promising signals for certain outcomes.
For example, while Omega-3 fatty acids (fish oil) showed only a small, but non-significant, reduction in the primary cardiovascular endpoint of major CVD events, they were associated with significant reductions in heart attacks.
The greatest treatment benefit was seen in people with dietary fish intake below the cohort median of 1.5 servings per week but not in those whose intake was above that level.
The heart health benefits are now confirmed by recent meta-analyses of omega-3 randomised trials.
Similarly, vitamin D supplementation did not reduce major CVD events or total cancer incidence but was associated with a statistically significant reduction in total cancer mortality among those in the trial at least two years.
The effect of vitamin D in reducing cancer death is also confirmed by updated meta-analyses of vitamin D trials to date.
The study is scheduled to be presented during The North American Menopause Society (NAMS) Annual Meeting in Chicago, September 25-28.
(This story was auto-published from a syndicated feed. No part of the story has been edited by FIT .)
(This story was published from a syndicated feed. Only the headline and picture has been edited by FIT)
Subscribe to FIT on Telegram